Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Nervous System Fungal Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT06389513
What this trial is testing

Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants

Who this might be right for
Epidemic Meningitis
CanSino Biologics Inc. 3,011
Not applicableStudy completedNCT00002076
What this trial is testing

Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

Who this might be right for
Meningitis, CryptococcalHIV Infections
Pfizer
Testing effectiveness (Phase 2)Study completedNCT00037479
What this trial is testing

Brain Imaging and Retreatment Study of Persistent Lyme Disease

Who this might be right for
Lyme DiseaseLyme Neuroborreliosis
National Institute of Neurological Disorders and Stroke (NINDS) 65
Large-scale testing (Phase 3)Study completedNCT00797511
What this trial is testing

Immunogenicity and Safety of Adacel Polio Vaccine

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi 132
Large-scale testing (Phase 3)Study completedNCT00772928
What this trial is testing

Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™

Who this might be right for
DiphtheriaTetanusHaemophilus Infection+2 more
Sanofi 1,167
Large-scale testing (Phase 3)Study completedNCT06011200
What this trial is testing

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population

Who this might be right for
Epidemic Meningitis
CanSino Biologics Inc. 1,000
Not applicableLooking for participantsNCT06338215
What this trial is testing

Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality

Who this might be right for
All Cause MortalityCardiovascular DiseasesInvasive Cancer+7 more
Clinica Universidad de Navarra, Universidad de Navarra 10,000
Large-scale testing (Phase 3)Study completedNCT06700148
What this trial is testing

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Year Olds

Who this might be right for
Meningococcal Meningitis
CanSino Biologics Inc. 840
Large-scale testing (Phase 3)Study completedNCT03891758
What this trial is testing

Confirmatory Study of BK1310 in Healthy Infants

Who this might be right for
TetanusDiphtheriaPertussis+2 more
Tanabe Pharma Corporation 267
Large-scale testing (Phase 3)Study completedNCT01214837
What this trial is testing

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 751
Not applicableUnknownNCT02624453
What this trial is testing

Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS

Who this might be right for
Cryptococcal Meningitis
ANRS, Emerging Infectious Diseases 186
Large-scale testing (Phase 3)Study completedNCT00944034
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,588
Post-approval studies (Phase 4)Study completedNCT01823536
What this trial is testing

Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose

Who this might be right for
Meningococcal Disease
Novartis Vaccines 465
Not applicableLooking for participantsNCT07027475
What this trial is testing

Acute Treatment and Long-term Assessment of Adult Infectious Meningitis

Who this might be right for
Viral MeningitisBacterial MeningitisFungal Meningitis+1 more
Hospital Israelita Albert Einstein 624
Not applicableStudy completedNCT02500511
What this trial is testing

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 50
Large-scale testing (Phase 3)Ended earlyNCT00664209
What this trial is testing

Treating H. Pylori in Parkinson's Patients With Motor Fluctuations

Who this might be right for
Parkinson's DiseaseHelicobacter InfectionsMotor Fluctuations
University of California, Los Angeles 64
Post-approval studies (Phase 4)Study completedNCT01535469
What this trial is testing

Operational Research for Cryptococcal Antigen Screening

Who this might be right for
Cryptococcal MeningitisCryptococcus NeoformansCryptococcosis
University of Minnesota 3,049
Not applicableWithdrawnNCT00770419
What this trial is testing

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more
Rutgers, The State University of New Jersey
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Post-approval studies (Phase 4)Study completedNCT00514059
What this trial is testing

Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Norwegian Institute of Public Health 83
Next Page